Corporate Information And Statement Of Ifrs Compliance [Abstract]

Zealand Pharma - Filing #1350008

Concept As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2022-12-31
Corporate information and statement of IFRS compliance [abstract]
Domicile of entity
Denmark
Legal form of entity
A/S
Description of nature of entity's operations and principal activities
Statement of IFRS compliance [text block]
Materiality
Disclosure of reclassifications or changes in presentation [text block]
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [text block]
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [abstract]
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [line items]
Current inventories
7,935,000 DKK
1,286,000 DKK
Disclosure of material accounting policy information [text block]

Talk to a Data Expert

Have a question? We'll get back to you promptly.